Presidential Symposium Saturday June 17

Meet-the-Expert Sessions | Simultaneous Sessions | Clinical Trial Update Session | Science in Progress Session | Hematology-in-Focus Sessions | Lunch Debates | EHA/ASH Joint Symposium | EHA Business Meeting | Plenary Session I | Presidential Symposium - 6 best abstracts | Scientific Working Groups | Poster Session II

PRESIDENTIAL SYMPOSIUM

16:00 - 17:30 hours, Auditorium

PRESIDENTIAL SYMPOSIUM: 6 BEST ABSTRACTS
Chairs: E. Hellström-Lindberg (Karolinska Institutet, Stockholm, Sweden) A. Hagenbeek (Academic Medical Center, Amsterdam, The Netherlands)

16:00 - 16:15 0530 HSV-TK DONOR LYMPHOCYTE ADD-BACKS ENABLE A WIDER USE OF HAPLOIDENTICAL ALLOGENEIC TRANSPLANTATION BY REDUCING INFECTION RELATED MORTALITY AND IMPROVING SURVIVAL IN HIGH RISK ACUTE LEUKEMIA
F. Ciceri, C. Bonini, M.T. Lupo Stanghellini, P. Bruzzi, A. Santoro, J. Apperley, S. Slavin, S. Toma, C. Gallo Stampino, M. Bregni, M. Bernardi, J. Peccatori, P. Servida, C. Bordignon (San Raffaele Scientific Institute, Milano, Italy) 16:15 - 16:30 0531 DIFFERENTIAL IMMUNOMODULATION OF ENGRAFTMENT FOLLOWING MHC-MISMATCHED HEMATOPOIETIC STEM CELL TRANSPLANTATION BY CO-TRANSPLANTATION OF HOST VERSUS DONOR MESENCHYMAL STEM CELLS
A.J. Nauta, A.B. Kruisselbrink, E. Lurvink, G. Westerhuis, R. Willemze, W.E. Fibbe (Leiden University Medical Center, Leiden, The Netherlands) 16:30 - 16:45 0532 SUSTAINED RECONSTITUTION OF NADPH-OXIDASE ACTIVITY IN X-LINKED CHRONIC GRANULOMATOUS DISEASE FOLLOWING RETROVIRAL GENE THERAPY AND NONMYELOABLATIVE CONDITIONING
M.G. Ott, M. Schmidt, S. Stein, U. Siler, K. Schwarzwaelder, U. Koehl, K. Kuehlcke, A. Schilz, A. Trasher, D. Hoelzer, C. von Kalle, R. Seger, M. Grez (University of Frankfurt, Frankfurt, Germany) 16:45 - 17:00 0533 IDENTIFICATION OF THE VON WILLEBRAND FACTOR BINDING SITE IN COLLAGEN USING TRIPLE HELICAL PEPTIDES
T. Lisman, N. Raynal, D. Groeneveld, B. Maddox, A. Peachey, E.G. Huizinga, P.G. de Groot, R.W. Farndale ( Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands) 17:00 - 17:15 0534 PTEN CONTROLS HEMATOPOIETIC STEM CELLS AND PREVENTS LEUKEMOGENESIS
G.M. Oser, A. Wilson, H. Wu, A. Trumpp (ISREC, Epalinges, Switzerland) 17:15 - 17:30 0535 SAFETY AND EFFICACY OF THE TERMINAL COMPLEMENT INHIBITOR ECULIZUMAB IN A PHASE III TRIAL IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
P. Hillmen, N.S. Young, J. Schubert, R.A. Brodsky, G. Socié, P. Muus, A. Röth, J. Szer, M.O. Elebute, R. Nakamura, P. Browne, A.M. Risitano, S.A. Rollins, C.F. Mojcik, R.P. Rother, L. Luzzatto (Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom)